Also under development are other small molecular compounds that interfere directly with the enzymatic action of particular coagulation factors (e.g., rivaroxaban, dabigatran, apixaban).
Tamén en desenvolvemento están outros pequenos compostos que interfiren directamente coa acción encimática de determinados factores de coagulación (por exemplo, rivaroxaban, dabigatran, apixaban).